Open this publication in new window or tab >>Ohio State Univ, Pelotonia Inst Immuno Oncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA..
Johns Hopkins Univ, Baltimore, MD USA..
Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH USA..
Ohio State Univ, Pelotonia Inst Immuno Oncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA..
Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH USA..
Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH USA..
Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH USA..
Ohio State Univ, Pelotonia Inst Immuno Oncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA..
Ohio State Univ, Pelotonia Inst Immuno Oncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA..
Ohio State Univ, Pelotonia Inst Immuno Oncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA..
Ohio State Univ, Pelotonia Inst Immuno Oncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA.;Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH USA..
Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH USA..
Ohio State Univ, Abigail Wexner Res Inst, Ctr Childhood Canc, Dept Pediat,Nationwide Childrens Hosp, Columbus, OH USA..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Thoracic Surgery. Emory Univ, Dept Pathol & Lab Med, Atlanta, GA USA.
Emory Univ, Dept Pathol & Lab Med, Atlanta, GA USA..
Emory Univ, Dept Pathol & Lab Med, Atlanta, GA USA..
Emory Univ, Dept Pathol & Lab Med, Atlanta, GA USA..
Ohio State Univ, Pelotonia Inst Immuno Oncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA.;Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH USA..
Ohio State Univ, Pelotonia Inst Immuno Oncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA.;Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH USA..
Ohio State Univ, Pelotonia Inst Immuno Oncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA.;Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH USA..
Ohio State Univ, Pelotonia Inst Immuno Oncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA.;Ohio State Univ, Coll Med, Dept Med, Div Med Oncol, Columbus, OH 43210 USA..
Show others...
2025 (English)In: Nature, ISSN 0028-0836, E-ISSN 1476-4687, Vol. 647, no 8091, p. 1025-1035Article in journal (Refereed) Published
Abstract [en]
Chronic infections and cancer cause T cell dysfunction known as exhaustion. This cell state is caused by persistent antigen exposure, suboptimal co-stimulation and a plethora of hostile factors that dampen protective immunity and limit the efficacy of immunotherapies1,2,3,4. The mechanisms that underlie T cell exhaustion remain poorly understood. Here we analyse the proteome of CD8+ exhausted T (Tex) cells across multiple states of exhaustion in the context of both chronic viral infections and cancer. We show that there is a non-stochastic pathway-specific discordance between mRNA and protein dynamics between T effector (Teff) and Tex cells. We identify a distinct proteotoxic stress response (PSR) in Tex cells, which we term Tex-PSR. Contrary to canonical stress responses that induce a reduction in protein synthesis5,6, Tex-PSR involves an increase in global translation activity and an upregulation of specialized chaperone proteins. Tex-PSR is further characterized by the accumulation of protein aggregates and stress granules and an increase in autophagy-dominant protein catabolism. We establish that disruption of proteostasis alone can convert Teff cells to Tex cells, and we link Tex-PSR mechanistically to persistent AKT signalling. Finally, disruption of Tex-PSR-associated chaperones in CD8+ T cells improves cancer immunotherapy in preclinical models. Moreover, a high Tex-PSR in T cells from patients with cancer confers poor responses to clinical immunotherapy. Collectively, our findings indicate that Tex-PSR is a hallmark and a mechanistic driver of T cell exhaustion, which raises the possibility of targeting proteostasis pathways as an approach for cancer immunotherapy.
Place, publisher, year, edition, pages
Springer Nature, 2025
National Category
Cancer and Oncology Immunology in the Medical Area Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-584072 (URN)10.1038/s41586-025-09539-1 (DOI)001585063000001 ()41034580 (PubMedID)2-s2.0-105017666135 (Scopus ID)
Funder
Swedish Research Council, 2023-00510
2026-05-042026-05-042026-05-04Bibliographically approved